{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T19:28:19Z","timestamp":1780514899725,"version":"3.54.1"},"reference-count":142,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T00:00:00Z","timestamp":1627084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sensors"],"abstract":"<jats:p>Prostate cancer (PCa) remains one of the most prominent forms of cancer for men. Since the early 1990s, Prostate-Specific Antigen (PSA) has been a commonly recognized PCa-associated protein biomarker. However, PSA testing has been shown to lack in specificity and sensitivity when needed to diagnose, monitor and\/or treat PCa patients successfully. One enhancement could include the simultaneous detection of multiple PCa-associated protein biomarkers alongside PSA, also known as multiplexing. If conventional methods such as the enzyme-linked immunosorbent assay (ELISA) are used, multiplexed detection of such protein biomarkers can result in an increase in the required sample volume, in the complexity of the analytical procedures, and in adding to the cost. Using companion diagnostic devices such as biosensors, which can be portable and cost-effective with multiplexing capacities, may address these limitations. This review explores recent research for multiplexed PCa protein biomarker detection using optical and electrochemical biosensor platforms. Some of the novel and potential serum-based PCa protein biomarkers will be discussed in this review. In addition, this review discusses the importance of converting research protocols into multiplex point-of-care testing (xPOCT) devices to be used in near-patient settings, providing a more personalized approach to PCa patients\u2019 diagnostic, surveillance and treatment management.<\/jats:p>","DOI":"10.3390\/s21155023","type":"journal-article","created":{"date-parts":[[2021,7,25]],"date-time":"2021-07-25T22:07:00Z","timestamp":1627250820000},"page":"5023","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Multiplexed Prostate Cancer Companion Diagnostic Devices"],"prefix":"10.3390","volume":"21","author":[{"given":"Josephine","family":"Aidoo-Brown","sequence":"first","affiliation":[{"name":"Centre for Biosensors, Bioelectronics and Biodevices (C3Bio), Department of Electronic & Electrical Engineering, University of Bath, Claverton Down, Bath BA2 7AY, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9175-5852","authenticated-orcid":false,"given":"Despina","family":"Moschou","sequence":"additional","affiliation":[{"name":"Centre for Biosensors, Bioelectronics and Biodevices (C3Bio), Department of Electronic & Electrical Engineering, University of Bath, Claverton Down, Bath BA2 7AY, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6956-1146","authenticated-orcid":false,"given":"Pedro","family":"Estrela","sequence":"additional","affiliation":[{"name":"Centre for Biosensors, Bioelectronics and Biodevices (C3Bio), Department of Electronic & Electrical Engineering, University of Bath, Claverton Down, Bath BA2 7AY, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,7,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"899","DOI":"10.4065\/80.7.899","article-title":"Adenocarcinoma of the prostate: Epidemiological trends, screening, diagnosis, and surgical management of localized disease","volume":"80","author":"Routh","year":"2005","journal-title":"Mayo Clin. Proc."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"890697","DOI":"10.1155\/2014\/890697","article-title":"Novel tools for prostate cancer prognosis, diagnosis, and follow-up","volume":"2014","author":"Dimakakos","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jcb.22227","article-title":"Biomarkers for prostate cancer","volume":"108","author":"Leman","year":"2009","journal-title":"J. Cell Biochem."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"037551","DOI":"10.1149\/1945-7111\/ab69fd","article-title":"Review\u2014Recent advances in electrochemical detection of prostate specific antigen (PSA) in clinically-relevant samples","volume":"167","author":"Traynor","year":"2020","journal-title":"J. Electrochem. Soc."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"107932","DOI":"10.1016\/j.pharmthera.2021.107932","article-title":"Prostate cancer biomarkers: From diagnosis to prognosis and precision-guided therapeutics","volume":"228","author":"Adamaki","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s11255-005-0921-x","article-title":"The value of PSA, free-to-total PSA ratio and PSA density in the prediction of pathologic stage for clinically localized prostate cancer","volume":"37","author":"Aslan","year":"2005","journal-title":"Int. Urol. Nephrol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/sj.pcan.4501026","article-title":"New circulating biomarkers for prostate cancer","volume":"11","author":"Bensalah","year":"2008","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s00345-003-0393-5","article-title":"Probability of prostate cancer as a function of the percentage of free prostate-specific antigen in patients with a non-suspicious rectal examination and total prostate-specific antigen of 4\u201310 ng\/mL","volume":"22","author":"Tabernero","year":"2004","journal-title":"World J. Urol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1002\/cncr.24357","article-title":"Techniques and predictive models to improve prostate cancer detection","volume":"115","author":"Herman","year":"2009","journal-title":"Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/2051415816656121","article-title":"Novel biomarkers for the detection of prostate cancer","volume":"9","author":"Jakobsen","year":"2016","journal-title":"J. Clin. Urol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/(SICI)1097-0045(19990301)38:4<296::AID-PROS5>3.0.CO;2-P","article-title":"Efficiency of prostate-specific antigen and digital rectal examination in screening, using 4.0 ng\/mL and age-specific reference range as a cutoff for abnormal values","volume":"38","author":"Crawford","year":"1999","journal-title":"Prostate"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.urology.2005.04.058","article-title":"Prostate cancer in patients with an abnormal digital rectal examination and serum prostate-specific antigen less than 4.0 ng\/mL","volume":"66","author":"Bozeman","year":"2005","journal-title":"Urology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0090-4295(95)96812-1","article-title":"Interexaminer variability of digital rectal examination in detecting prostate cancer","volume":"45","author":"Smith","year":"1995","journal-title":"Urology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.urology.2007.07.019","article-title":"Characteristics of prostate cancer detected by digital rectal examination Only","volume":"70","author":"Okotie","year":"2007","journal-title":"Urology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1016\/j.bios.2011.05.005","article-title":"Microfluidic electrochemical immunoarray for ultrasensitive detection of to cancer biomarker proteins in serum","volume":"26","author":"Chikkaveeraiah","year":"2011","journal-title":"Biosens. Bioelectron."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1002\/elan.201800193","article-title":"Electrochemical biosensing in cancer diagnostics and follow-up","volume":"30","author":"Freitas","year":"2018","journal-title":"Electroanalysis"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"6546","DOI":"10.1021\/nn3023969","article-title":"Electrochemical immunosensors for detection of cancer protein biomarkers","volume":"6","author":"Chikkaveeraiah","year":"2012","journal-title":"ACS Nano"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1002\/elan.201600183","article-title":"Multiplex immunosensor arrays for electrochemical detection of cancer biomarker proteins","volume":"28","author":"Munge","year":"2016","journal-title":"Electroanalysis"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00345-010-0583-x","article-title":"Use of a combination of biomarkers in serum and urine to improve detection of prostate cancer","volume":"28","author":"Prior","year":"2010","journal-title":"World J. Urol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.tibtech.2017.03.013","article-title":"Multiplexed point-of-care resting\u2013xPOCT","volume":"35","author":"Dincer","year":"2017","journal-title":"Trends Biotechnol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Primiceri, E., Chiriac\u00f2, M.S., Notarangelo, F.M., Crocamo, A., Ardissino, D., Cereda, M., Bramanti, A.P., Bianchessi, M.A., Giannelli, G., and Maruccio, G. (2018). Key enabling technologies for point-of-care diagnostics. Sensors, 18.","DOI":"10.3390\/s18113607"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.clgc.2019.02.003","article-title":"Application of urinary volatile organic compounds (VOCs) for the diagnosis of prostate cancer","volume":"17","author":"Gao","year":"2019","journal-title":"Clin. Genitourin. Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsbmb.2016.04.009","article-title":"The importance of DNA methylation in prostate cancer development","volume":"166","author":"Massie","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.bios.2019.03.065","article-title":"Prostate cancer biomarkers detection using nanoparticles based electrochemical biosensors","volume":"137","author":"Singh","year":"2019","journal-title":"Biosens. Bioelectron."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Khalid, T., Aggio, R., White, P., De Lacy Costello, B., Persad, R., Al-Kateb, H., Jones, P., Probert, C.S., and Ratcliffe, N. (2015). Urinary volatile organic compounds for the detection of prostate cancer. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0143283"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bios.2017.08.045","article-title":"Trimetallic Pd@Au@Pt nanocomposites platform on -COOH terminated reduced graphene oxide for highly sensitive CEA and PSA biomarkers detection","volume":"100","author":"Barman","year":"2018","journal-title":"Biosens. Bioelectron."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.euus.2005.09.005","article-title":"Molecular diagnostics in prostate cancer","volume":"3","author":"Hessels","year":"2005","journal-title":"EAU Update Ser."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.bios.2019.04.048","article-title":"Gold interdigitated triple-microelectrodes for label-free prognosticative aptasensing of prostate cancer biomarker in serum","volume":"136","author":"Ibau","year":"2019","journal-title":"Biosens. Bioelectron."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"6411","DOI":"10.1021\/acsomega.8b00634","article-title":"Bioconjugated, single-use biosensor for the detection of biomarkers of prostate cancer","volume":"3","author":"Yao","year":"2018","journal-title":"ACS Omega."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1039\/c0an00204f","article-title":"Measurement of biomarker proteins for point-of-care early detection and monitoring of cancer","volume":"135","author":"Rusling","year":"2010","journal-title":"Analyst"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/0284186X.2010.542174","article-title":"Tumor markers in prostate cancer I: Blood-based markers","volume":"50","author":"Shariat","year":"2011","journal-title":"Acta Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev.med.60.042307.110714","article-title":"Biomarkers for prostate cancer","volume":"60","author":"Makarov","year":"2009","journal-title":"Annu. Rev. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11255-007-9236-4","article-title":"Diagnostic efficacy of free to total ratio of prostate-specific antigen and prostate-specific antigen velocity, singly and in combination, in detecting prostate cancer in patients with total serum prostate-specific antigen between 4 and 10 ng\/mL","volume":"40","author":"Yamamoto","year":"2008","journal-title":"Int. Urol. Nephrol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1258\/000456304323019569","article-title":"Comparison of total, complexed and free prostate-specific antigens and their ratios in the detection of prostate cancer in a non-screened population","volume":"41","author":"McArdle","year":"2004","journal-title":"Ann. Clin. Biochem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/nrc2351","article-title":"Prostate-specific antigen and prostate cancer: Prediction, detection and monitoring","volume":"8","author":"Lilja","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.eururo.2005.04.015","article-title":"Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2\u201310 ng\/mL: Systematic review and meta-analysis","volume":"48","author":"Roddam","year":"2005","journal-title":"Eur. Urol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.biotechadv.2016.11.009","article-title":"Prostate cancer diagnostics: Clinical challenges and the ongoing need for disruptive and effective diagnostic tools","volume":"35","author":"Sharma","year":"2017","journal-title":"Biotechnol. Adv."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1001\/jama.279.19.1542","article-title":"Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: A prospective multicenter clinical trial","volume":"279","author":"Catalona","year":"1998","journal-title":"JAMA"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1464-410X.2007.07283.x","article-title":"New blood-based biomarkers for the diagnosis, staging and prognosis of prostate cancer","volume":"101","author":"Shariat","year":"2008","journal-title":"BJU Int."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Becerra, M.F., Atluri, V.S., Bhattu, A.S., and Punnen, S. (2020). Serum and urine biomarkers for detecting clinically significant prostate cancer. Urol. Oncol., in press.","DOI":"10.1016\/j.urolonc.2020.02.018"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.juro.2014.10.121","article-title":"The prostate health index selectively identifies clinically significant prostate cancer","volume":"193","author":"Loeb","year":"2015","journal-title":"J. Urol."},{"key":"ref_42","first-page":"221","article-title":"The use of biomarkers in prostate cancer screening and treatment","volume":"19","author":"Alford","year":"2017","journal-title":"Rev. Urol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"150","DOI":"10.7150\/jca.1.150","article-title":"Novel diagnostic biomarkers for prostate cancer","volume":"1","author":"Madu","year":"2010","journal-title":"J. Cancer"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Biomarkers Definitions Working Group (2001). Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin. Pharmacol. Ther., 69, 89\u201395.","DOI":"10.1067\/mcp.2001.113989"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/03008880510030941","article-title":"Prognostic value of serum markers for prostate cancer","volume":"39","author":"Stenman","year":"2005","journal-title":"Scand. J. Urol. Nephrol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/pcan.2008.2","article-title":"Beyond prostate-specific antigen: Alternate serum markers","volume":"11","author":"Nelson","year":"2008","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s12032-014-0140-3","article-title":"Biomarkers in prostate cancer: New era and prospective","volume":"31","author":"Mohammed","year":"2014","journal-title":"Med. Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"12620","DOI":"10.3390\/ijms140612620","article-title":"The present and future of prostate cancer urine biomarkers","volume":"14","author":"Rigau","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"11034","DOI":"10.3390\/ijms140611034","article-title":"Current status of biomarkers for prostate cancer","volume":"14","author":"Velonas","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2217\/bmm.12.72","article-title":"Biomarkers for the diagnosis of new and recurrent prostate cancer","volume":"6","author":"Sardana","year":"2012","journal-title":"Biomark. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.snb.2015.05.049","article-title":"Optimisation of an electrochemical impedance spectroscopy aptasensor by exploiting quartz crystal microbalance with dissipation signals","volume":"220","author":"Formisano","year":"2015","journal-title":"Sens. Actuators B Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"7569","DOI":"10.1021\/acs.analchem.8b01198","article-title":"Automated 3D-printed microfluidic array for rapid nanomaterial-enhanced detection of multiple proteins","volume":"90","author":"Kadimisetty","year":"2018","journal-title":"Anal. Chem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2058739218812665","article-title":"Serum and tissue monocyte differentiation in PSA value 4\u201310\u2009ng\/mL prostate cancer and benign prostatic hyperplasia","volume":"16","author":"Guo","year":"2018","journal-title":"Eur. J. Inflamm."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1080\/08820130802403242","article-title":"CD14 expression in the first 24 h of sepsis: Effect of \u2212260C > T CD14 SNP","volume":"37","author":"Girardi","year":"2008","journal-title":"Immunol. Investig."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/elan.201800632","article-title":"Multiplexed electrochemical cancer diagnostics with automated microfluidics","volume":"31","author":"Mercer","year":"2019","journal-title":"Electroanalysis"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.archger.2005.09.008","article-title":"The chromogranin-A (CgA) in prostate cancer","volume":"43","author":"Ranno","year":"2006","journal-title":"Arch. Gerontol. Geriatr."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/pros.20806","article-title":"GOLPH2 and MYO6: Putative prostate cancer markers localized to the Golgi apparatus","volume":"68","author":"Wei","year":"2008","journal-title":"Prostate"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1073\/pnas.0914061107","article-title":"Inherited genetic variant predisposes to aggressive but not indolent prostate cancer","volume":"107","author":"Xu","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1593\/neo.08922","article-title":"Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancer","volume":"10","author":"Varambally","year":"2008","journal-title":"Neoplasia"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.talanta.2018.05.070","article-title":"Classification analyses for prostate cancer, benign prostate hyperplasia and healthy subjects by SERS-based immunoassay of multiple tumour markers","volume":"188","author":"Zhou","year":"2018","journal-title":"Talanta"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/jnci\/90.12.911","article-title":"Insulin-like growth factor 1 and prostate cancer risk: A population-based, case-control study","volume":"90","author":"Wolk","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1158\/1055-9965.EPI-06-1062","article-title":"Serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 concentrations and prostate cancer risk: Results from the European Prospective Investigation into Cancer and Nutrition","volume":"16","author":"Allen","year":"2007","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.urolonc.2005.12.004","article-title":"Insulin-like growth factors and their binding proteins in prostate cancer: Cause or consequence?","volume":"24","author":"Meinbach","year":"2006","journal-title":"Urol. Oncol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/S1096-6374(00)90015-7","article-title":"Insulin-like growth factor I (IGF-I), IGF-binding protein-3 and prostate cancer risk: Epidemiological studies","volume":"10","author":"Chan","year":"2000","journal-title":"Growth Horm. IGF Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3892\/or.2012.1832","article-title":"Emerging biomarkers of prostate cancer (Review)","volume":"28","author":"Martin","year":"2012","journal-title":"Oncol. Rep."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1634\/theoncologist.2011-0321","article-title":"Changes in biomarkers of inflammation and angiogenesis during androgen deprivation therapy for prostate cancer","volume":"17","author":"Saylor","year":"2012","journal-title":"Oncologist"},{"key":"ref_67","first-page":"2702","article-title":"Serum interleukin 6 as a prognostic factor in patients with prostate cancer","volume":"6","author":"Nakashima","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"9129","DOI":"10.1021\/ac9018022","article-title":"Single-wall carbon nanotube forest arrays for immunoelectrochemical measurement of four protein biomarkers for prostate cancer","volume":"81","author":"Chikkaveeraiah","year":"2009","journal-title":"Anal. Chem."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"20137","DOI":"10.1021\/am505726b","article-title":"Flexible gold electrode array for multiplexed immunoelectrochemical measurement of three protein biomarkers for prostate cancer","volume":"6","author":"Liu","year":"2014","journal-title":"ACS Appl. Mater. Imterfaces"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1182\/blood-2007-04-084798","article-title":"Platelet-associated PF-4 as a biomarker of early tumor growth","volume":"111","author":"Cervi","year":"2008","journal-title":"Blood"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1016\/S0049-3848(12)70026-9","article-title":"CXCL4-platelet factor 4, heparin-induced thrombocytopenia and cancer","volume":"129","author":"Sandset","year":"2012","journal-title":"Thromb. Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.thromres.2009.11.023","article-title":"Role of the platelet chemokine platelet factor 4 (PF4) in hemostasis and thrombosis","volume":"125","author":"Kowalska","year":"2010","journal-title":"Thromb. Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2010.10.011","article-title":"The role of the CXC chemokines platelet factor-4 (CXCL4\/PF-4) and its variant (CXCL4L1\/PF-4var) in inflammation, angiogenesis and cancer","volume":"22","author":"Vandercappellen","year":"2011","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1002\/pmic.200401165","article-title":"Mass profiling-directed isolation and identification of a stage-specific serologic protein biomarker of advanced prostate cancer","volume":"5","author":"Lam","year":"2005","journal-title":"Proteomics"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"549","DOI":"10.4103\/1008-682X.129211","article-title":"Current early diagnostic biomarkers of prostate cancer","volume":"16","author":"Qu","year":"2014","journal-title":"Asian J. Androl."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1093\/clinchem\/27.10.1747","article-title":"Comparison of countercurrent immunoelectrophoretic assay with commerical radioimmunoassay kits for measuring prostatic acid phosphatase","volume":"27","author":"Wright","year":"1981","journal-title":"Clin. Chem."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4062\/biomolther.2012.095","article-title":"Emerging roles of human prostatic acid phosphatase","volume":"21","author":"Kong","year":"2013","journal-title":"Biomol. Ther."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/1758834017719215","article-title":"Prognostic and predictive biomarkers in prostate cancer: Latest evidence and clinical implications","volume":"9","author":"Terada","year":"2017","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref_79","first-page":"6029","article-title":"Quantitation of serum prostate-specific membrane antigen by a novel protein biochip immunoassay discriminates benign from malignant prostate disease","volume":"61","author":"Xiao","year":"2001","journal-title":"Cancer Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1200\/JCO.2006.05.6853","article-title":"Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis","volume":"25","author":"Shariat","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.eururo.2008.01.034","article-title":"Serum markers for prostate cancer: A rational approach to the literature","volume":"54","author":"Steuber","year":"2008","journal-title":"Eur. Urol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(02)00789-1","article-title":"Platelets and cancer","volume":"3","author":"Nash","year":"2002","journal-title":"Lancet Oncol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1158\/1078-0432.584.11.2","article-title":"Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: Expression of lymphangiogenic markers is associated with advanced-stage disease","volume":"11","author":"Kaushal","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.trac.2007.05.007","article-title":"Biomedical and clinical applications of immunoassays and immunosensors for tumor markers","volume":"26","author":"Wu","year":"2007","journal-title":"Trends Anal. Chem."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.bios.2013.02.052","article-title":"Simultaneous and combined detection of multiple tumor biomarkers for prostate cancer in human serum by suspension array technology","volume":"47","author":"Liu","year":"2013","journal-title":"Biosens. Bioelectron."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.bios.2018.08.015","article-title":"Simultaneous immunoassays of dual prostate cancer markers using a SERS-based microdroplet channel","volume":"119","author":"Gao","year":"2018","journal-title":"Biosens. Bioelectron."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.bios.2014.06.060","article-title":"The simultaneous detection of free and total prostate antigen in serum samples with high sensitivity and specificity by using the dual-channel surface plasmon resonance","volume":"62","author":"Jiang","year":"2014","journal-title":"Biosens. Bioelectron."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"112093","DOI":"10.1016\/j.bios.2020.112093","article-title":"A challenge in biosensors: Is it better to measure a photon or an electron for ultrasensitive detection?","volume":"155","author":"Roda","year":"2020","journal-title":"Biosens. Bioelectron."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/978-981-15-9612-4_3","article-title":"Strategies for multiplexed electrochemical sensor development","volume":"Volume 327","author":"Dutta","year":"2021","journal-title":"Modern Techniques in Biosensors. Studies in Systems, Decision and Control"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Mej\u00eda-Salazar, J.R., Rodrigues Cruz, K., Mater\u00f3n V\u00e1sques, E.M., and Novais de Oliveira Jr., O. (2020). Microfluidic point-of-care devices: New trends and future prospects for eHealth diagnostics. Sensors, 20.","DOI":"10.3390\/s20071951"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"083001","DOI":"10.1088\/1361-6439\/aa7117","article-title":"Biosensors-on-chip: A topical review","volume":"27","author":"Shamsi","year":"2017","journal-title":"J. Micromech. Microeng."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Bouffier, L., and Sojic, N. (2020). Introduction and overview of electrogenerated chemiluminescence. Analytical Electrogenerated Chemiluminescence: From Fundamentals to Bioassays, The Royal Society of Chemistry.","DOI":"10.1039\/9781788015776-00001"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"8727","DOI":"10.1007\/s00216-016-0032-9","article-title":"Highlights of analytical chemical luminescence and cataluminescence","volume":"408","author":"Roda","year":"2016","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev-anchem-062012-092616","article-title":"Microfluidic chips for immunoassays","volume":"6","author":"Han","year":"2013","journal-title":"Annu. Rev. Anal. Chem."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"111719","DOI":"10.1016\/j.bios.2019.111719","article-title":"Dual-color magnetic-quantum dot nanobeads as versatile fluorescent probes in test strip for simultaneous point-of-care detection of free and complexed prostate-specific antigen","volume":"145","author":"Rong","year":"2019","journal-title":"Biosens. Bioelectron."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Miao, W. (2007). Electrogenerated chemiluminescence. Handbook of Electrochemistry, Elsevier.","DOI":"10.1016\/B978-044451958-0.50026-4"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/09540105.2016.1272550","article-title":"A review of enhancers for chemiluminescence enzyme immunoassay","volume":"28","author":"Chen","year":"2017","journal-title":"Food Agric. Immunol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1021\/acs.analchem.9b05080","article-title":"Multiplexed immunosensors and immunoarrays","volume":"92","author":"Jones","year":"2020","journal-title":"Anal. Chem."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1039\/C6LC01238H","article-title":"Automated 3D-printed unibody immunoarray for chemiluminescence detection of cancer biomarker proteins","volume":"17","author":"Tang","year":"2017","journal-title":"Lab Chip"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.bios.2015.12.058","article-title":"DNA aptamer-based sandwich microfluidic assays for dual quantification and multi-glycan profiling of cancer biomarkers","volume":"79","author":"Jolly","year":"2016","journal-title":"Biosens. Bioelectron."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"20180077","DOI":"10.1098\/rsfs.2018.0077","article-title":"Prostate-specific antigen glycoprofiling as diagnostic and prognostic biomarker of prostate cancer","volume":"9","author":"Tkac","year":"2019","journal-title":"Interface Focus"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/bio.3358","article-title":"Dual-labeled chemiluminescence enzyme immunoassay for simultaneous measurement of total prostate specific antigen (TPSA) and free prostate specific antigen (FPSA)","volume":"32","author":"Zhao","year":"2017","journal-title":"Luminescence"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1146\/annurev-anchem-060908-155305","article-title":"Electrogenerated chemiluminescence","volume":"2","author":"Forster","year":"2009","journal-title":"Annu. Rev. Anal. Chem."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1021\/acs.analchem.9b03425","article-title":"Electrogenerated chemiluminescence biosensing","volume":"92","author":"Qi","year":"2020","journal-title":"Anal. Chem."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"6698","DOI":"10.1021\/ac201292q","article-title":"Carbon nanotube microwell array for sensitive electrochemiluminescent detection of cancer biomarker proteins","volume":"83","author":"Sardesai","year":"2011","journal-title":"Anal. Chem."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1007\/s00216-012-6656-5","article-title":"A microfluidic electrochemiluminescent device for detecting cancer biomarker proteins","volume":"405","author":"Sardesai","year":"2013","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1021\/acs.analchem.5b00421","article-title":"Automated multiplexed ECL immunoarrays for cancer biomarker proteins","volume":"87","author":"Kadimisetty","year":"2015","journal-title":"Anal. Chem."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.bios.2015.09.017","article-title":"3D-printed supercapacitor-powered electrochemiluminescent protein immunoarray","volume":"77","author":"Kadimisetty","year":"2016","journal-title":"Biosens. Bioelectron."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1021\/acs.analchem.6b03536","article-title":"Simultaneous detection of dual nucleic acids using a SERS-based lateral flow assay biosensor","volume":"89","author":"Wang","year":"2017","journal-title":"Anal. Chem."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"116122","DOI":"10.1016\/j.trac.2020.116122","article-title":"Towards translation of surface-enhanced Raman spectroscopy (SERS) to clinical practice: Progress and trends","volume":"134","author":"Panikar","year":"2021","journal-title":"Trends Anal. Chem."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1039\/b708461g","article-title":"SERS as a bioassay platform: Fundamentals, design, and applications","volume":"37","author":"Porter","year":"2008","journal-title":"Chem. Soc. Rev."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0925-4005(98)00321-9","article-title":"Surface plasmon resonance sensors: Review","volume":"54","author":"Homola","year":"1999","journal-title":"Sens. Actuators B Chem."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Smolsky, J., Kaur, S., Hayashi, C., Batra, S.K., and Krasnoslobodtsev, A.V. (2017). Surface-enhanced Raman scattering-based immunoassay technologies for detection of disease biomarkers. Biosensors, 7.","DOI":"10.3390\/bios7010007"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"112524","DOI":"10.1016\/j.bios.2020.112524","article-title":"Portable and multiplexed lateral flow immunoassay reader based on SERS for highly sensitive point-of-care testing","volume":"168","author":"Xiao","year":"2020","journal-title":"Biosens. Bioelectron."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1039\/C9AN00733D","article-title":"Vertical flow assays based on core-shell SERS nanotags for multiplex prostate cancer biomarker detection","volume":"144","author":"Chen","year":"2019","journal-title":"Analyst"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.trac.2019.05.014","article-title":"Development of electrochemical biosensors for tumor marker determination towards cancer diagnosis: Recent progress","volume":"118","author":"Sadighbayan","year":"2019","journal-title":"Trends Anal. Chem."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.bios.2017.11.029","article-title":"Electrochemical immunosensors\u2013A powerful tool for analytical applications","volume":"102","author":"Felix","year":"2018","journal-title":"Biosens. Bioelectron."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"037525","DOI":"10.1149\/2.0252003JES","article-title":"Review\u2014Measurement and analysis of cancer biomarkers based on electrochemical biosensors","volume":"167","author":"Cui","year":"2020","journal-title":"J. Electrochem. Soc."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.bios.2016.12.052","article-title":"Fe3O4 nanoparticles on graphene oxide sheets for isolation and ultrasensitive amperometric detection of cancer biomarker proteins","volume":"91","author":"Sharafeldin","year":"2017","journal-title":"Biosens. Bioelectron."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.bios.2013.09.054","article-title":"On-line protein capture on magnetic beads for ultrasensitive microfluidic immunoassays of cancer biomarkers","volume":"53","author":"Otieno","year":"2014","journal-title":"Biosens. Bioelectron."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1593\/neo.10726","article-title":"Antibody-based detection of ERG rearrangement-positive prostate cancer","volume":"12","author":"Park","year":"2010","journal-title":"Neoplasia"},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Deisingh, A.K., Guiseppi-Wilson, A., and Guiseppi-Elie, A. (2009). Biochip platforms for DNA diagnostics. Microarrays: Preparation, Microfluidics, Detection Methods, and Biological Applications, Springer.","DOI":"10.1007\/978-0-387-72719-6_14"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1021\/acssensors.6b00256","article-title":"High-throughput electrochemical microfluidic immunoarray for multiplexed detection of cancer biomarker proteins","volume":"1","author":"Tang","year":"2016","journal-title":"ACS Sens."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.bios.2016.01.077","article-title":"An electrochemical biosensor to simultaneously detect VEGF and PSA for early prostate cancer diagnosis based on graphene oxide\/ssDNA\/PLLA nanoparticles","volume":"89","author":"Pan","year":"2017","journal-title":"Biosens. Bioelectron."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/elsc.201800093","article-title":"An electrochemical biosensor for prostate cancer biomarker detection using graphene oxide\u2013gold nanostructures","volume":"19","author":"Shayeh","year":"2019","journal-title":"Eng. Life Sci."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1007\/s00216-008-1970-7","article-title":"The use of electrochemical impedance spectroscopy for biosensing","volume":"391","author":"Lisdat","year":"2008","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1039\/C0LC00409J","article-title":"EIS microfluidic chips for flow immunoassay and ultrasensitive cholera toxin detection","volume":"11","author":"Primiceri","year":"2011","journal-title":"Lab Chip"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"4227","DOI":"10.1016\/j.electacta.2009.01.081","article-title":"Impedimetric immunosensors\u2014A review","volume":"55","author":"Prodromidis","year":"2010","journal-title":"Electrochim. Acta"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.1039\/c3an00911d","article-title":"On-chip screening for prostate cancer: An EIS microfluidic platform for contemporary detection of free and total PSA","volume":"138","author":"Primiceri","year":"2013","journal-title":"Analyst"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1039\/C5AN02322J","article-title":"Sensitive detection and glycoprofiling of a prostate specific antigen using impedimetric assays","volume":"141","author":"Belicky","year":"2016","journal-title":"Analyst"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"112872","DOI":"10.1016\/j.bios.2020.112872","article-title":"Impedimetric aptamer-based glycan PSA score for discrimination of prostate cancer from other prostate diseases","volume":"175","author":"Estrela","year":"2021","journal-title":"Biosens. Bioelectron."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/2211068215581349","article-title":"Development and applications of portable biosensors","volume":"20","author":"Srinivasan","year":"2015","journal-title":"J. Lab. Autom."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"30011","DOI":"10.3390\/s151229783","article-title":"Microfluidics integrated biosensors: A leading technology towards Lab-on-a-Chip and sensing applications","volume":"15","author":"Luka","year":"2015","journal-title":"Sensors"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nature05058","article-title":"The origins and the future of microfluidics","volume":"442","author":"Whitesides","year":"2006","journal-title":"Nature"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1042\/EBC20150013","article-title":"Lab-on-chip systems for integrated bioanalyses","volume":"60","author":"Conde","year":"2016","journal-title":"Essays Biochem."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1039\/C7LC00121E","article-title":"The lab-on-PCB approach: Tackling the \u03bcTAS commercial upscaling bottleneck","volume":"17","author":"Moschou","year":"2017","journal-title":"Lab Chip"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.bios.2018.09.006","article-title":"A PNA-based Lab-on-PCB diagnostic platform for rapid and high sensitivity DNA quantification","volume":"123","author":"Jolly","year":"2019","journal-title":"Biosens. Bioelectron."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3892\/br.2016.586","article-title":"Prostate cancer markers: An update (Review)","volume":"4","author":"Pentyala","year":"2016","journal-title":"Biomed. Rep."},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Sharafeldin, M., Jones, A., and Rusling, J.F. (2018). 3D-printed biosensor arrays for medical diagnostics. Micromachines, 9.","DOI":"10.20944\/preprints201806.0292.v1"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"342","DOI":"10.2174\/1874944501912010342","article-title":"Assessing reliability of commercially available point of care in various clinical fields","volume":"12","author":"Pezzuto","year":"2019","journal-title":"Open Public Health J."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1002\/elan.201600248","article-title":"Development of electrochemical immunosensors towards point-of-care cancer diagnostics: Clinically relevant studies","volume":"28","author":"Laocharoensuk","year":"2016","journal-title":"Electroanalysis"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1039\/C7AN01771E","article-title":"Advances in point-of-care diagnostic devices in cancers","volume":"143","author":"Banerjee","year":"2018","journal-title":"Analyst"}],"container-title":["Sensors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8220\/21\/15\/5023\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:34:20Z","timestamp":1760164460000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8220\/21\/15\/5023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,24]]},"references-count":142,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["s21155023"],"URL":"https:\/\/doi.org\/10.3390\/s21155023","relation":{},"ISSN":["1424-8220"],"issn-type":[{"value":"1424-8220","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,24]]}}}